Galapagos Slumps as It Drops Promise of Profit: Brussels Mover

Galapagos NV, a Belgian drug developer, fell the most in more than a year after reporting a full-year loss and dropping a promise to become profitable.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.